Stay updated on Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.

Latest updates to the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAn added 'Revision: v3.3.3' notice appears in the page footer, and the 'HHS Vulnerability Disclosure' link as well as the older 'Revision: v3.3.2' entry have been removed. These are administrative updates to the site's footer and revision history rather than changes to the study data or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe study history page now shows Revision v3.3.2 and no longer shows v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedNotice about lapse in government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check66 days agoChange DetectedThere are no substantive changes to study details or recruitment status between the screenshots; only the page layout and history list appear updated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedNew date and study status have been added, replacing an older dated entry. This signals updated scheduling/progress tracking for the study content.SummaryDifference0.9%

- Check87 days agoChange DetectedMajor change: page now advertises current government operating status and a version update to v3.2.0; previous v3.1.0 is removed.SummaryDifference10%

Stay in the know with updates to Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.